197 related articles for article (PubMed ID: 23919107)
1. Risk factors and classifications of hilar cholangiocarcinoma.
Suarez-Munoz MA; Fernandez-Aguilar JL; Sanchez-Perez B; Perez-Daga JA; Garcia-Albiach B; Pulido-Roa Y; Marin-Camero N; Santoyo-Santoyo J
World J Gastrointest Oncol; 2013 Jul; 5(7):132-8. PubMed ID: 23919107
[TBL] [Abstract][Full Text] [Related]
2. New staging system and a registry for perihilar cholangiocarcinoma.
Deoliveira ML; Schulick RD; Nimura Y; Rosen C; Gores G; Neuhaus P; Clavien PA
Hepatology; 2011 Apr; 53(4):1363-71. PubMed ID: 21480336
[TBL] [Abstract][Full Text] [Related]
3. Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.
Xu X; Yang L; Chen W; He M
J Int Med Res; 2021 May; 49(5):3000605211008336. PubMed ID: 33983055
[TBL] [Abstract][Full Text] [Related]
4. [Cholangiocarcinoma].
Burgos San Juan L
Rev Med Chil; 2008 Feb; 136(2):240-8. PubMed ID: 18483680
[TBL] [Abstract][Full Text] [Related]
5. Management of perihilar cholangiocarcinoma in the era of multimodal therapy.
Valero V; Cosgrove D; Herman JM; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):481-95. PubMed ID: 22928900
[TBL] [Abstract][Full Text] [Related]
6. [TNM staging of hilar cholangiocarcinoma].
Kim HJ
Korean J Gastroenterol; 2005 Jul; 46(1):20-7. PubMed ID: 16030400
[TBL] [Abstract][Full Text] [Related]
7. [Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].
Lu Z; Wang DD
Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):488-91. PubMed ID: 27373472
[TBL] [Abstract][Full Text] [Related]
8. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.
Nagino M
J Gastroenterol; 2012 Nov; 47(11):1165-76. PubMed ID: 22847554
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma.
Passeri MJ; Baimas-George MR; Sulzer JK; Iannitti DA; Martinie JB; Baker EH; Ocuin LM; Vrochides D
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):157-162. PubMed ID: 32088126
[TBL] [Abstract][Full Text] [Related]
11. Concomitant hilar cholangiocarcinoma with choledochal cyst and cholelithiasis in an asymptomatic patient: A case report.
Gyawali S; Adhikari G; Shrestha S; Pradhan S; Bhandari RS
Int J Surg Case Rep; 2021 Jul; 84():106094. PubMed ID: 34139420
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center.
Lidsky ME; Jarnagin WR
Ann Gastroenterol Surg; 2018 Jul; 2(4):304-312. PubMed ID: 30003193
[TBL] [Abstract][Full Text] [Related]
13. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma.
Bird N; Elmasry M; Jones R; Elniel M; Kelly M; Palmer D; Fenwick S; Poston G; Malik H
Br J Surg; 2017 Mar; 104(4):418-425. PubMed ID: 27861766
[TBL] [Abstract][Full Text] [Related]
14. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
15. [Concept of perihilar cholangiocarcinoma in the General Rules for Clinical and Pathological Studies on Cancer of the Biliary Tract, 6th edition].
Ebata T; Yokoyama Y; Sugawara G; Igami T; Mizuno T; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Kokuryo T; Nagino M
Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):201-5. PubMed ID: 25154239
[TBL] [Abstract][Full Text] [Related]
16. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.
Rungsakulkij N; Sornmayura P; Tannaphai P
BMC Surg; 2017 Feb; 17(1):17. PubMed ID: 28202062
[TBL] [Abstract][Full Text] [Related]
17. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.
Rocha FG; Matsuo K; Blumgart LH; Jarnagin WR
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):490-6. PubMed ID: 19806295
[TBL] [Abstract][Full Text] [Related]
18. [Comprehensive measures for improving the radical resection rate and safety of Bismuth-Corlette type III hilar cholangiocarcinoma].
Wang JD; Shen J; Zhou XP; Zhuang PY; Zhou D; Yang Y; Liu YB; Quan ZW
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):596-9. PubMed ID: 24256583
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
20. Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation.
Mar WA; Shon AM; Lu Y; Yu JH; Berggruen SM; Guzman G; Ray CE; Miller F
Abdom Radiol (NY); 2016 Mar; 41(3):553-67. PubMed ID: 26847022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
